Gaudium IVF Q2 FY27 Consolidated Results and IPO Object Revision
Gaudium IVF and Women Health Ltd · Change in Management · 13 Nov 2026, 2:26 am
Gaudium IVF Q2 FY27 Consolidated Results and IPO Object Revision Gaudium IVF reported consolidated revenue of ₹3,741.11 lakhs for the quarter ended 30th Sep'26, up 17.9% YoY and 93.1% QoQ. Consolidated net profit reached ₹941.31 lakhs compared to ₹937.91 lakhs in the year-ago period and ₹177.59 lakhs in Q1 FY27, with diluted EPS at ₹1.29. The Board approved substituting 6 locations and revising the timeline to establish 19 new IVF centres by FY29 within the existing ₹5,000 lakhs IPO allocation, alongside appointing Dr. Ravish Manchanda as National Head – Operations Expansion & Strategy.
Original exchange filing (PDF)
More announcements from Gaudium IVF and Women Health Ltd
- Gaudium IVF and Women Health Limited has informed the Exchange about audio recording of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half .... · 17 Nov 2026
- Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 15 Nov 2026
- Rectification of inadvertent typographical error in the unaudited consolidated financial results for the quarter and half year ended September 30,2026 · 13 Nov 2026
- Monitoring Agency Report for quarter ended September 30, 2026 · 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange regarding revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. · 13 Nov 2026
- Revised Code of Practices and Procedures for fair Disclosure of Unpubulished Price Sensitive Information Pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. · 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 13 Nov 2026
- Statement of Deviation(s) or variation(s) Under Regulation 32 for the quarter ended September 30, 2026. · 13 Nov 2026
